• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

用于评估肝癌患者消融区域的简化磁共振成像方案

Abbreviated MRI Protocol for the Assessment of Ablated Area in HCC Patients.

作者信息

Granata Vincenza, Grassi Roberta, Fusco Roberta, Setola Sergio Venanzio, Belli Andrea, Piccirillo Mauro, Pradella Silvia, Giordano Marzia, Cappabianca Salvatore, Brunese Luca, Grassi Roberto, Petrillo Antonella, Izzo Francesco

机构信息

Radiology Division, "Istituto Nazionale Tumori IRCCS Fondazione Pascale-IRCCS di Napoli", 80131 Naples, Italy.

Division of Radiology, University of Campania Luigi Vanvitelli, 80127 Naples, Italy.

出版信息

Int J Environ Res Public Health. 2021 Mar 30;18(7):3598. doi: 10.3390/ijerph18073598.

DOI:10.3390/ijerph18073598
PMID:33808466
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8037601/
Abstract

BACKGROUND

Liver Imaging Reporting and Data Systems (LI-RADS) Treatment Response Algorithm (TRA) was created to provide a standardized assessment of hepatocellular carcinoma (HCC) following loco regional therapy. The aim of this study was to compare sensitivity of standard MRI protocol versus abbreviated protocol (only T1-Weigthed fat suppressed (FS) sequences pre- and post-contrast phase) in the detection of ablated area according to LI-RADS Treatment Response (LR-TR) categories.

METHODS

From January 2015 to June 2020, we selected 64 patients with HCC, who underwent Radiofrequency ablation (RFA) or Microwave ablation (MWA) treatment. According to inclusion criteria, 136 pathologically proven treated HCC (median 2, range 1-3 per patient; mean size 20.0 mm; range 15-30 mm) in 58 patients (26 women, 32 men; median age, 74 years; range, 62-83 years) comprised our study population. For each ablated area, abbreviated protocol, and standard Magnetic Resonance Imaging (MRI) studies were independently and blindly assessed in random order within and between three expert radiologists. Each radiologist assessed the ablated area by using the following categories: "LR-TR Non-viable" = 1; "LR-TR Equivocal" = 2 and "LR-TR Viable" = 0.

RESULTS

According to the concordance between MRI and Contrast enhancement ultrasound (CEUS) among 136 treated HCCs, 115 lesions were assessed as non-viable or totally ablate and 21 as viable or partially ablate. The accuracy for standard MRI protocol and abbreviated MRI protocol for predicting pathologic tumor viability of a consensus reading was 98.6% (sensitivity = 100%; specificity = 98.3%; positive predictive value = 91.3% and negative predictive value = 100%). No differences were found in sensitivity or specificity between standard MRI LR-TR viable and abbreviated MRI LR-TR viable categories ( value > 0.05 at McNemar test).

CONCLUSION

The abbreviated dynamic protocol showed similar diagnostic accuracy to conventional MRI study in the assessment of treated HCCs, with a reduction of the acquisition study time of 30% respect to conventional MRI.

摘要

背景

肝脏影像报告和数据系统(LI-RADS)治疗反应算法(TRA)旨在对局部区域治疗后的肝细胞癌(HCC)进行标准化评估。本研究的目的是根据LI-RADS治疗反应(LR-TR)分类,比较标准MRI方案与简化方案(仅在对比剂增强前后的T1加权脂肪抑制(FS)序列)在检测消融区域方面的敏感性。

方法

2015年1月至2020年6月,我们选择了64例接受射频消融(RFA)或微波消融(MWA)治疗的HCC患者。根据纳入标准,58例患者(26例女性,32例男性;中位年龄74岁;范围62-83岁)中136个经病理证实的治疗性HCC(每位患者中位数2个,范围1-3个;平均大小20.0mm;范围15-30mm)构成了我们的研究人群。对于每个消融区域,简化方案和标准磁共振成像(MRI)研究由三位专家放射科医生在内部和之间以随机顺序独立且盲法进行评估。每位放射科医生使用以下分类评估消融区域:“LR-TR无活性”=1;“LR-TR不确定”=2和“LR-TR有活性”=0。

结果

根据136个治疗性HCC中MRI与对比增强超声(CEUS)之间的一致性,115个病变被评估为无活性或完全消融,21个为有活性或部分消融。标准MRI方案和简化MRI方案预测病理肿瘤活性的共识读数的准确性为98.6%(敏感性=100%;特异性=98.3%;阳性预测值=91.3%,阴性预测值=100%)。标准MRI LR-TR有活性类别和简化MRI LR-TR有活性类别之间在敏感性或特异性方面未发现差异(McNemar检验时P值>0.05)。

结论

简化动态方案在评估治疗后的HCC方面显示出与传统MRI研究相似的诊断准确性,与传统MRI相比,采集研究时间减少了30%。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fe07/8037601/fb22798afdc2/ijerph-18-03598-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fe07/8037601/bfad8ef675c0/ijerph-18-03598-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fe07/8037601/b382545a3ef5/ijerph-18-03598-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fe07/8037601/111846d9a342/ijerph-18-03598-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fe07/8037601/28074ff358e3/ijerph-18-03598-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fe07/8037601/615207ce7c1f/ijerph-18-03598-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fe07/8037601/3b17a04a51fb/ijerph-18-03598-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fe07/8037601/fb22798afdc2/ijerph-18-03598-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fe07/8037601/bfad8ef675c0/ijerph-18-03598-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fe07/8037601/b382545a3ef5/ijerph-18-03598-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fe07/8037601/111846d9a342/ijerph-18-03598-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fe07/8037601/28074ff358e3/ijerph-18-03598-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fe07/8037601/615207ce7c1f/ijerph-18-03598-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fe07/8037601/3b17a04a51fb/ijerph-18-03598-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fe07/8037601/fb22798afdc2/ijerph-18-03598-g007.jpg

相似文献

1
Abbreviated MRI Protocol for the Assessment of Ablated Area in HCC Patients.用于评估肝癌患者消融区域的简化磁共振成像方案
Int J Environ Res Public Health. 2021 Mar 30;18(7):3598. doi: 10.3390/ijerph18073598.
2
LI-RADS version 2018 treatment response algorithm on extracellular contrast-enhanced MRI in patients treated with transarterial chemoembolization for hepatocellular carcinoma: diagnostic performance and the added value of ancillary features.LI-RADS 版本 2018 经动脉化疗栓塞治疗肝细胞癌患者的细胞外对比增强 MRI 治疗反应算法:诊断性能和辅助特征的附加价值。
Abdom Radiol (NY). 2024 Sep;49(9):3045-3055. doi: 10.1007/s00261-024-04275-y. Epub 2024 Apr 11.
3
Diagnostic Performance of LI-RADS Treatment Response Algorithm for Hepatocellular Carcinoma: Adding Ancillary Features to MRI Compared with Enhancement Patterns at CT and MRI.LI-RADS 治疗反应算法对肝细胞癌的诊断性能:与 CT 和 MRI 的增强模式相比,添加 MRI 的辅助特征。
Radiology. 2020 Sep;296(3):554-561. doi: 10.1148/radiol.2020192797. Epub 2020 Jul 21.
4
Incorporation of Ancillary MRI Features Into the LI-RADS Treatment Response Algorithm: Impact on Diagnostic Performance After Locoregional Treatment of Hepatocellular Carcinoma.将辅助 MRI 特征纳入 LI-RADS 治疗反应算法:对肝细胞癌局部治疗后诊断性能的影响。
AJR Am J Roentgenol. 2022 Mar;218(3):484-493. doi: 10.2214/AJR.21.26677. Epub 2021 Sep 29.
5
Liver imaging reporting and data system (LI-RADS) v2018: Reliability and agreement for assessing hepatocellular carcinoma locoregional treatment response.肝脏影像报告和数据系统 (LI-RADS) v2018:评估肝细胞癌局部区域治疗反应的可靠性和一致性。
Diagn Interv Imaging. 2022 Nov;103(11):524-534. doi: 10.1016/j.diii.2022.06.007. Epub 2022 Jul 2.
6
Diagnostic accuracy of contrast-enhanced ultrasound for the differential diagnosis of hepatocellular carcinoma: ESCULAP versus CEUS-LI-RADS.超声造影对肝细胞癌鉴别诊断的诊断准确性:爱克发与CEUS-LI-RADS对比
Eur J Gastroenterol Hepatol. 2017 Sep;29(9):1036-1044. doi: 10.1097/MEG.0000000000000916.
7
The LI-RADS Version 2018 MRI Treatment Response Algorithm: Evaluation of Ablated Hepatocellular Carcinoma.LI-RADS 版本 2018 MRI 治疗反应算法:消融治疗肝细胞癌的评估。
Radiology. 2020 Feb;294(2):320-326. doi: 10.1148/radiol.2019191581. Epub 2019 Dec 17.
8
LI-RADS treatment response categorization on gadoxetic acid-enhanced MRI: diagnostic performance compared to mRECIST and added value of ancillary features.钆塞酸增强 MRI 的 LI-RADS 治疗反应分类:与 mRECIST 的诊断性能比较及辅助特征的附加价值。
Eur Radiol. 2020 May;30(5):2861-2870. doi: 10.1007/s00330-019-06623-9. Epub 2020 Jan 31.
9
Validation of the Liver Imaging Reporting and Data System Treatment Response Criteria After Thermal Ablation for Hepatocellular Carcinoma.肝肿瘤热消融治疗后 Liver Imaging Reporting and Data System 治疗应答标准的验证。
Liver Transpl. 2020 Feb;26(2):203-214. doi: 10.1002/lt.25673. Epub 2019 Dec 20.
10
Per-patient Negative Predictive Value of the CT and MRI Liver Imaging Reporting and Data System Version 2018 Treatment Response Algorithm for Hepatocellular Carcinoma.基于 CT 和 MRI 肝脏影像报告和数据系统 2018 版治疗反应算法的肝癌每例患者阴性预测值。
Radiology. 2023 Dec;309(3):e222776. doi: 10.1148/radiol.222776.

引用本文的文献

1
Radiomics Beyond Radiology: Literature Review on Prediction of Future Liver Remnant Volume and Function Before Hepatic Surgery.放射组学超越放射学:肝脏手术前预测未来肝剩余体积和功能的文献综述
J Clin Med. 2025 Jul 28;14(15):5326. doi: 10.3390/jcm14155326.
2
Radiomics and machine learning analysis by computed tomography and magnetic resonance imaging in colorectal liver metastases prognostic assessment.基于计算机断层扫描和磁共振成像的影像组学与机器学习分析在结直肠癌肝转移预后评估中的应用
Radiol Med. 2023 Nov;128(11):1310-1332. doi: 10.1007/s11547-023-01710-w. Epub 2023 Sep 11.
3
Dictionary learning LASSO for feature selection with application to hepatocellular carcinoma grading using contrast enhanced magnetic resonance imaging.

本文引用的文献

1
Gadoxetate-enhanced Abbreviated MRI for Hepatocellular Carcinoma Surveillance: Preliminary Experience.钆塞酸增强简化MRI用于肝细胞癌监测:初步经验
Radiol Imaging Cancer. 2019 Nov 29;1(2):e190010. doi: 10.1148/rycan.2019190010. eCollection 2019 Nov.
2
Abbreviated MRI for hepatocellular carcinoma screening: A systematic review and meta-analysis.用于肝细胞癌筛查的简化 MRI:系统评价和荟萃分析。
J Hepatol. 2021 Jul;75(1):108-119. doi: 10.1016/j.jhep.2021.01.041. Epub 2021 Feb 3.
3
Alternative approach of hepatocellular carcinoma surveillance: abbreviated MRI.
用于特征选择的字典学习套索算法及其在基于对比增强磁共振成像的肝细胞癌分级中的应用
Front Oncol. 2023 Apr 6;13:1123493. doi: 10.3389/fonc.2023.1123493. eCollection 2023.
4
Colorectal liver metastases patients prognostic assessment: prospects and limits of radiomics and radiogenomics.结直肠癌肝转移患者的预后评估:影像组学和影像基因组学的前景与局限
Infect Agent Cancer. 2023 Mar 16;18(1):18. doi: 10.1186/s13027-023-00495-x.
5
Recent Advances in Ultrasound Breast Imaging: From Industry to Clinical Practice.超声乳腺成像的最新进展:从工业到临床实践
Diagnostics (Basel). 2023 Mar 4;13(5):980. doi: 10.3390/diagnostics13050980.
6
Radiation Recall Pneumonitis: The Open Challenge in Differential Diagnosis of Pneumonia Induced by Oncological Treatments.放射性回忆性肺炎:肿瘤治疗所致肺炎鉴别诊断中的公开挑战
J Clin Med. 2023 Feb 10;12(4):1442. doi: 10.3390/jcm12041442.
7
Risk Assessment and Cholangiocarcinoma: Diagnostic Management and Artificial Intelligence.风险评估与胆管癌:诊断管理与人工智能
Biology (Basel). 2023 Jan 29;12(2):213. doi: 10.3390/biology12020213.
8
Imaging Features of Main Hepatic Resections: The Radiologist Challenging.肝主要切除术的影像学特征:放射科医生面临的挑战。
J Pers Med. 2023 Jan 10;13(1):134. doi: 10.3390/jpm13010134.
9
Immunotherapy Assessment: A New Paradigm for Radiologists.免疫疗法评估:放射科医生的新范例
Diagnostics (Basel). 2023 Jan 13;13(2):302. doi: 10.3390/diagnostics13020302.
10
Risk Assessment and Pancreatic Cancer: Diagnostic Management and Artificial Intelligence.风险评估与胰腺癌:诊断管理与人工智能
Cancers (Basel). 2023 Jan 5;15(2):351. doi: 10.3390/cancers15020351.
肝细胞癌监测的替代方法:简化磁共振成像
Hepatoma Res. 2020;6. doi: 10.20517/2394-5079.2020.50. Epub 2020 Sep 1.
4
Assessment of Ablation Therapy in Pancreatic Cancer: The Radiologist's Challenge.胰腺癌消融治疗的评估:放射科医生面临的挑战。
Front Oncol. 2020 Nov 27;10:560952. doi: 10.3389/fonc.2020.560952. eCollection 2020.
5
Hepatocellular carcinoma Liver Imaging Reporting and Data Systems treatment response assessment: Lessons learned and future directions.肝细胞癌肝脏影像报告和数据系统治疗反应评估:经验教训与未来方向。
World J Hepatol. 2020 Oct 27;12(10):738-753. doi: 10.4254/wjh.v12.i10.738.
6
LI-RADS to categorize liver nodules in patients at risk of HCC: tool or a gadget in daily practice?LI-RADS 用于分类 HCC 风险患者的肝脏结节:日常实践中的工具还是小玩意?
Radiol Med. 2021 Jan;126(1):5-13. doi: 10.1007/s11547-020-01225-8. Epub 2020 May 26.
7
Application of the ESR iGuide clinical decision support system to the imaging pathway of patients with hepatocellular carcinoma and cholangiocarcinoma: preliminary findings.ESR iGuide 临床决策支持系统在肝细胞癌和胆管细胞癌患者影像学路径中的应用:初步研究结果。
Radiol Med. 2020 Jun;125(6):531-537. doi: 10.1007/s11547-020-01142-w. Epub 2020 Feb 4.
8
Characterization of the arterial enhancement pattern of focal liver lesions by multiple arterial phase magnetic resonance imaging: comparison between hepatocellular carcinoma and focal nodular hyperplasia.多期动脉期磁共振成像对肝脏局灶性病变增强模式的特征分析:肝细胞癌与局灶性结节增生的比较。
Radiol Med. 2020 Apr;125(4):348-355. doi: 10.1007/s11547-019-01127-4. Epub 2020 Jan 8.
9
HCC screening: assessment of an abbreviated non-contrast MRI protocol.肝细胞癌筛查:一种简化的非增强磁共振成像方案的评估
Eur Radiol Exp. 2019 Dec 18;3(1):49. doi: 10.1186/s41747-019-0126-1.
10
Qualitative assessment of EOB-GD-DTPA and Gd-BT-DO3A MR contrast studies in HCC patients and colorectal liver metastases.HCC患者和结直肠癌肝转移患者中EOB-GD-DTPA和Gd-BT-DO3A磁共振对比研究的定性评估
Infect Agent Cancer. 2019 Nov 27;14:40. doi: 10.1186/s13027-019-0264-3. eCollection 2019.